Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)
Status:
Completed
Trial end date:
2009-12-26
Target enrollment:
Participant gender:
Summary
A cross-over, polysomnography study to test the safety, tolerability and effectiveness of
different doses of suvorexant (MK-4305) in the treatment of patients with primary insomnia.